shrimp

Case 1 (Baotailai)

The shrimp farm has experienced an outbreak of shrimp liver and intestinal parasite disease. Some shrimp ponds have been continuously using the shrimp liver and intestinal parasite binding protein product from HiTide Company for five days. Samples were taken and sent for testing from both ponds that used the binding protein product and those that did not. The test results showed that the shrimp ponds using shrimp hepatosporosis binding protein products had negative pathogen detection results for shrimp hepatosporosis, indicating effective control of the disease in these ponds. In contrast, shrimp ponds that did not use shrimp hepatosporozoite binding protein products tested positive for the pathogen of shrimp hepatosporozoite, with a detection content of up to 3.23 × 10⁶copies/μl， This indicates that the shrimp hepatointestinal sporozoite disease in these shrimp ponds is still ongoing.

This comparison result indicates that the shrimp liver and intestinal sporozoite binding protein product of Haiteda Company can effectively control shrimp liver and intestinal sporozoite disease.

Case 2 (Baotailai)

The South American white shrimp in the shrimp farm has been confirmed to be infected with shrimp hepatointestinal disease through testing. Before using the shrimp liver enterosporum binding protein product from HiTide Company, the initial detection level of shrimp liver enterosporum was 24.33 copies/μ l. Subsequently, the shrimp farm used the product continuously for six days and conducted testing again. The results showed that the detection level of shrimp hepatointestinal sporozoite decreased to 0 copies/μ l, indicating that the shrimp hepatointestinal sporozoite disease in the shrimp farm has successfully turned negative. This result further confirms the effectiveness of shrimp liver enterosporosis binding protein products in controlling shrimp liver enterosporosis. By continuously using this product, shrimp farms can significantly reduce the infection level of shrimp hepatointestinal parasites, protect the health of shrimp populations, and thus improve aquaculture efficiency.

Case Three (Baotailai)

Previously, there were consecutive outbreaks of liver and intestinal sporozoite in the shrimp pond, and the test results showed that the content was as high as 1 × 10⁵Copies/μ l or above. For this reason, farmers have taken measures to clear the pond. Afterwards, when the new shrimp larvae arrived, the farmers first conducted antigen testing for hepatic enterosporum, and found that the shrimp had been infected with the parasite. Although the current level is low, hepatic enterosporum has a tendency to rapidly reproduce and cause serious diseases. Therefore, the farmers immediately used Haitaida's hepatointestinal spore binding protein "Baotailai" for 7 consecutive days. After use, the shrimp body was tested again for liver and intestinal sporozoite, and the results showed zero detection content, which fully confirms the effectiveness of Baotailai in controlling shrimp liver and intestinal sporozoite disease.

Case Four (Zhongshan Shrimp - Prevention and Treatment with Baotailai)

The shrimp pond case in Zhongshan, Guangdong Province shows that the same batch of shrimp seedlings that tested negative for liver and intestinal sporozoites were placed in three shrimp ponds of the same area, labeled as 1B, 1C, and 1D. Among them, the 1C shrimp pond insisted on feeding three consecutive days a week with feed wrapped in Baotailai (liver and intestinal sporozoite adhesion protein), one meal a day, as a preventive measure.

After four weeks of continuous feeding, the shrimp feeding amount in the 1C shrimp pond of the experimental group remained normal, while the shrimp feeding amount in the control groups 1B and 1D shrimp ponds, which did not receive prevention with Baotailai (hepatointestinal spore adhesion protein), began to decrease. Subsequently, shrimp samples were collected for testing, and the results showed that the infection level of shrimp hepatointestinal spores in control group 1B shrimp pond was 185.69IU/ml, the infection level of shrimp hepatointestinal spores in control group 1D was 23.64IU/ml, and the content of shrimp hepatointestinal sporozoites in experimental group 1C shrimp pond was 0 IU/ml.

This result fully demonstrates that feeding Taelai shrimp with hepatointestinal sporozoites according to prevention procedures can effectively control hepatointestinal sporozoites, and the healthy cultivation of shrimp has significant positive significance.

Shrimp farmers' pond owners immediately took treatment measures for the control group of diseased shrimp ponds 1B and 1D. They mixed the feed with Baotailai for the treatment of hepatic and intestinal sporozoites, and fed it continuously for 7 days, with one meal per day. After 3 days of feeding, the shrimp feed intake in the two ponds returned to normal levels. After 7 days of feeding, samples were taken and tested, and the results were negative for hepatic enterosporum. The test results are shown in the following figure.

Control group shrimp pond 1B and 1D were fed with Bao Tailai treatment for 7 days, and the test results were obtained

Case 5 (Zhuhai Shrimp - Baotailai Treatment)

The farm has four shrimp ponds, each with an area of approximately 9-10 acres, labeled as 1-1 pond, 1-2 pond, 1-3 pond, and 3-5 pond respectively. In the initial detection, the EHP load of each pond was: 1-1 pond, 2.53 × 10⁷IU/ml； 1-2 ponds 5.68 × 10²IU/ml； 1-3 ponds 7.11 × 10⁰IU/ml； 3-5 ponds 3.71 × 10²IU/ml；。

Subsequently, the customer treated 1-1, 1-3, and 3-5 ponds with Baotailai for seven consecutive days, while 1-2 ponds did not receive this treatment. After the treatment was completed, the test results showed that the EHP load of 1-1 pond decreased to 6.8 × 10⁶IU/ml； The EHP load of ponds 1-3 and 3-5 decreased to 0IU/ml. And the EHP load of 1-2 ponds significantly increased to 2.89 × 10⁷IU/ml。

It is worth noting that a long period of heavy rainstorm occurred during the treatment, leading to irregular feeding procedures, which may have a certain impact on the treatment effect. Despite this, the treatment effect is still significant, with a decrease of about four times in the infection level of EHP in 1-1 ponds using Baotailai, while EHP in 1-3 ponds and 3-5 ponds completely turned negative, and both food intake and feeding speed significantly increased. On the contrary, the infection rate of EHP in 1-2 ponds without using Baotailai increased from 5.68 × 10²IU/ml significantly increased to 2.89 × 10⁷IU/ml， The feed intake has significantly decreased (data shown in the figure below).

Case 6 (Jiangsu Xiaopeng Shrimp - Baotailai Prevention)

There are a total of 520 small sheds in this area for breeding South American white shrimp, all of which are fed with Baotailai mixed feed from day 15 to day 60 to prevent liver and intestinal spore disease. Throughout the entire breeding process, all the shrimp in 520 small sheds did not experience an outbreak of liver and intestinal sporozoite disease, and the pathogen detection for sporozoite was negative.

Case Seven (Xiajitai)

A large number of dead shrimp appeared in four shrimp ponds at a shrimp joint experimental site in Nantong City, Jiangsu Province. The shrimp bodies turned white, and the muscles showed irregular block like and strip-shaped white turbidity, which is a typical Infectious myonecrosis. After sampling and testing, the shrimp in these four shrimp ponds were all confirmed to be infected with IMNV, with an average virus content of 55000 copies/mg, and the highest even reaching 128000 copies/mg.

Subsequently, the experimental site used HiTide's Infectious myonecrosis virus binding protein for seven consecutive days. Seven days later, the infected shrimp in the four shrimp ponds were almost impossible to see, and the overall situation was greatly improved. After re-sampling and testing, the results showed that the IMNV content in the shrimp pond had significantly decreased, with an average virus content of 1100 copies/mg and a maximum of only 1500 copies/mg.

This result demonstrates that the binding protein product can effectively eliminate IMNV and prevent the occurrence of infectious Infectious myonecrosis.

Case 8 (Xiahongtai)

At a white shrimp joint experimental site in Zhuhai, the initial load of shrimp rainbow virus was detected to be 4.244 × 10³UI/ml。 Subsequently, the experimental site used the shrimp WSSV virus binding protein from HiTide Company for seven consecutive days and conducted sampling and testing again. The results showed that the content of shrimp WSSV virus in the shrimp pond had been cleared to zero.

Case Nine (Xiahongtai)

At a joint testing site for Iridovirids in Zhuhai, the initial detection of shrimp Iridovirids virus was strongly positive. Subsequently, the experimental site used the shrimp Iridovirids virus binding protein from Haiteda Company for seven consecutive days and conducted sampling and testing again. The retest result of the Iridovirids virus in the shrimp pond was negative.

Case 10 (Xiabantai)

At a white shrimp joint experimental site in Dongying, the initial load of shrimp white spot virus was detected to be 26UI/ml. Subsequently, the experimental site used the shrimp white spot virus binding protein from Haiteda Company for seven consecutive days and conducted sampling and testing again. The results showed that the white spot virus content in the shrimp pond had been cleared to zero.